Product NDC: | 16714-202 |
Proprietary Name: | Cefadroxil |
Non Proprietary Name: | Cefadroxil |
Active Ingredient(s): | 250 mg/5mL & nbsp; Cefadroxil |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16714-202 |
Labeler Name: | Northstar Rx LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065307 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071107 |
Package NDC: | 16714-202-02 |
Package Description: | 50 mL in 1 BOTTLE (16714-202-02) |
NDC Code | 16714-202-02 |
Proprietary Name | Cefadroxil |
Package Description | 50 mL in 1 BOTTLE (16714-202-02) |
Product NDC | 16714-202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefadroxil |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20071107 |
Marketing Category Name | ANDA |
Labeler Name | Northstar Rx LLC |
Substance Name | CEFADROXIL |
Strength Number | 250 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |